Literature DB >> 25027069

Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.

Jeremy J Gilbreath1, Punam Verma2, April N Abbott1, Susan M Butler-Wu3.   

Abstract

We compared the Verigene Clostridium difficile test (Nanosphere, Northbrook, IL, USA), the Simplexa C. difficile Universal Direct (Focus Diagnostics, Cypress, CA, USA), the BD MAX Cdiff (Becton Dickinson, Franklin Lakes, NJ, USA), and the Xpert C. difficile (Cepheid, Sunnyvale, CA, USA) assays for the detection of toxigenic C. difficile. One hundred and ninety deidentified, remnant diarrheal specimens were included in this study. After resolution of discordant results by toxigenic culture, the Xpert C. difficile assay displayed the highest sensitivity (100%), with a specificity of 98.8%. The sensitivity and specificity were 95.2% and 99.4% and 87% and 100% for the Verigene CDF and Simplexa Universal Direct assays, respectively. Finally, the BD MAX assay showed a sensitivity of 87% and a specificity of 98.8%. Despite differences in the overall performance of these assays, these results support the routine use of these platforms for the detection of toxigenic C. difficile in the clinical laboratory.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDI; Clostridium difficile; Molecular diagnostics; RT-PCR; tcdB

Mesh:

Substances:

Year:  2014        PMID: 25027069     DOI: 10.1016/j.diagmicrobio.2014.06.001

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

1.  Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.

Authors:  Thais Simões Camargo; Moacyr Silva Junior; Luis Fernando Aranha Camargo; Veronica Pivetta Biotto; André Mario Doi; Paula Celia Mariko Koga; Carolina Nunes França; Marines Dalla Valle Martino
Journal:  Arch Microbiol       Date:  2021-01-18       Impact factor: 2.552

Review 2.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

3.  Simultaneous detection and characterization of toxigenic Clostridium difficile directly from clinical stool specimens.

Authors:  Hanjiang Lai; Chen Huang; Jian Cai; Julian Ye; Jun She; Yi Zheng; Liqian Wang; Yelin Wei; Weijia Fang; Xianjun Wang; Yi-Wei Tang; Yun Luo; Dazhi Jin
Journal:  Front Med       Date:  2017-10-17       Impact factor: 4.592

4.  Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.

Authors:  Hee-Won Moon; Hyeong Nyeon Kim; Mina Hur; Hee Sook Shim; Heejung Kim; Yeo-Min Yun
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

Review 5.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

6.  Clinical evaluation of a non-purified direct molecular assay for the detection of Clostridioides difficile toxin genes in stool specimens.

Authors:  Toshinori Hara; Hiromichi Suzuki; Tadatomo Oyanagi; Norito Koyanagi; Akihito Ushiki; Naoki Kawabata; Miki Goto; Yukio Hida; Yuji Yaguchi; Kiyoko Tamai; Shigeyuki Notake; Yosuke Kawashima; Akio Sugiyama; Keiichi Uemura; Seiya Kashiyama; Toru Nanmoku; Satoshi Suzuki; Hiroshi Yamazaki; Hideki Kimura; Hiroyuki Kunishima; Hiroki Ohge
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

7.  A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.

Authors:  Michael J Mashock; Matthew L Faron; Karen C Carroll; Christina Dang; Shawna Lewis; Hossein Salimnia; Paul Lephart; Vivian G Loo; Bryan H Schmitt; Stephen Young; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

8.  Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.

Authors:  Bo-Moon Shin; Sun Mee Yoo; Won Chang Shin
Journal:  Ann Lab Med       Date:  2016-03       Impact factor: 3.464

9.  Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis.

Authors:  Yuanyuan Bai; Xiaorong Sun; Yan Jin; Yueling Wang; Juan Li
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

10.  Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection.

Authors:  Paul A Granato; Glen Hansen; Emily Herding; Sheena Chaudhuri; Shaowu Tang; Sachin K Garg; Catherine R Rowell; Joanna Jackson Sickler
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.